The University of California, Los Angeles’ (UCLA) Jules Stein Eye Institute announced it has begun pursuing a long-term affiliation with the Doheny Eye Institute.
Los Angeles-The University of California, Los Angeles’ (UCLA) Jules Stein Eye Institute announced it has begun pursuing a long-term affiliation with the Doheny Eye Institute.
The proposed affiliation would preserve each organization’s identity and mission, combine clinical operations that would expand patient access in Los Angeles, and align strengths that have factored into advancing ophthalmology through research, outreach, education and patient care.
Both organizations are in the top 10 of the most recent U.S. News & World Report’s best hospital rankings for ophthalmology-Jules Stein Eye Institute is ranked No. 5 and the Doheny Eye Institute is ranked No. 9- which is based on feedback from fellow ophthalmology specialists on challenging cases and procedures.
“We are honored to work with the Doheny Eye Institute board in developing a plan to improve patient care throughout Southern California and at the same time extend the Jules Stein Eye Institute’s research and education efforts, which hold immense value for the nation and world,” said David Feinberg, MD, president of the UCLA Health System, chief executive officer of the UCLA Hospital System, and associate vice chancellor of the Geffen School of Medicine at UCLA.
“This is a rare and unique opportunity to strengthen relationships with our distinguished colleagues at Doheny, many of whom have long collaborated with us in serving the Los Angeles community,” he said.
Ed Landry, chairman of the Doheny Eye Institute board of directors, said he is looking forward “to fruitful negotiations.”
“With UCLA and the Jules Stein Eye Institute, we have identified a partner whose mission statement is complementary to ours and who shares our values and high standards for education, patient care, and research,” he said.
For more articles in this issue of Ophthalmology Times eReport, click here.
To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.